Clinical Trials Browser

OTHER × Pancreatic Neoplasms × irofulven × Clear all

NCT00003760 2012-08-09

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms